These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 10321635)

  • 1. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
    Tomaszewski MM; Moad JC; Lupton GP
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
    Vermeer MH; Bekkenk MW; Willemze R
    J Am Acad Dermatol; 2001 Oct; 45(4):638-40. PubMed ID: 11568767
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous CD30 (Ki-1)-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Terao H; Kiryu H; Ohshima K; Kikuchi M; Furue M
    J Dermatol; 2000 Mar; 27(3):170-3. PubMed ID: 10774143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
    Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
    Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
    Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
    Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
    Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
    Tomaszewski MM; Lupton GP; Krishnan J; May DL
    J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
    DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
    Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
    Magro CM; Momtahen S; Kiuru M
    Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous Ki-1+ anaplastic large cell lymphoma: a morphologic, immunohistochemical and genetic study of an indolent case.
    Sato N; Sato K; Yagi E; Tomita Y
    J Dermatol; 1995 Jun; 22(6):441-9. PubMed ID: 7650245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.
    Rubie H; Gladieff L; Robert A; Gaubert I; Huguet F; Rochaix P; Pein F; Michel G; Hoerni B; Sommelet D
    Med Pediatr Oncol; 1994; 22(3):155-61. PubMed ID: 8272005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-1(CD30) positive anaplastic large cell lymphoma: primary nodal disease relapsing as erythroderma.
    Goyal S; Brinster NK; Goyal S
    J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S201-4. PubMed ID: 12140462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
    Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 antigen in non-Hodgkin's lymphoma.
    Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
    Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
    Goyal A; Patel S; Goyal K; Morgan EA; Foreman RK
    J Cutan Pathol; 2019 Nov; 46(11):823-829. PubMed ID: 31286556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinico-pathological and immunohistochemical study on anaplastic large cell lymphoma].
    Jin X; Li C; Ding C; Chu Q
    Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):194-6. PubMed ID: 11869528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
    Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
    J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
    Sigel JE; Hsi ED
    Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.